PTC Therapeutics (PTCT) – Analyst EPS Change
-
BofA Securities Explains Its Underperform Rating on PTC Therapeutics (PTCT) While Raising the PT to $34
-
PTC Therapeutics (PTCT) PT Lowered to $65 at Truist Securities
-
-
-
-
-
Back to PTCT Stock Lookup